Editorial: co-existing immune-mediated disease in inflammatory bowel diseases - a new disease severity indicator?

Aliment Pharmacol Ther. 2017 Apr;45(8):1167. doi: 10.1111/apt.13987.

Authors

Z Vegh¹, T Bessissow², W Afif², P L Lakatos^{1

2}

Affiliations

¹ Semmelweis University, First Department of Medicine, Budapest, Hungary.
² Department of Gastroenterology, McGill University Health Center, Montreal General Hospital, Montreal, Canada.

PMID: 28326586
DOI: 10.1111/apt.13987

No abstract available

Publication types

Editorial
Comment

MeSH terms

Humans
Inflammatory Bowel Diseases*